<?xml version="1.0" encoding="UTF-8"?>

<document id="DDI-MedLine.d211"> 
   <sentence id="DDI-MedLine.d211.s0" text="Phase I trial of lenalidomide and CCI-779 in patients with relapsed multiple myeloma: evidence for lenalidomide-CCI-779 interaction via P-glycoprotein.
" new_text="Phase@@I@@trial@@of@@lenalidomide@@and@@CCI-779@@in@@patients@@with@@relapsed@@multiple@@myeloma@@:@@evidence@@for@@lenalidomide@@-@@CCI-779@@interaction@@via@@P-glycoprotein@@.@@"> 
      <entity id="DDI-MedLine.d211.s0.e0" charOffset="17-28" type="drug" text="lenalidomide" position="4"/>  
      <entity id="DDI-MedLine.d211.s0.e1" charOffset="34-40" type="drug" text="CCI-779" position="6"/>  
      <entity id="DDI-MedLine.d211.s0.e2" charOffset="99-110" type="drug" text="lenalidomide" position="16"/>  
      <entity id="DDI-MedLine.d211.s0.e3" charOffset="112-118" type="drug" text="CCI-779" position="18"/>  
      <pair id="DDI-MedLine.d211.s0.p0" e1="DDI-MedLine.d211.s0.e0" e2="DDI-MedLine.d211.s0.e1" ddi="false" flags="True" e1_name="lenalidomide" e2_name="CCI-779" e1_pos="4" e2_pos="6" path="4@@6@@">lenalidomide@@@@conj_and@@CCI-779</pair>  
      <pair id="DDI-MedLine.d211.s0.p1" e1="DDI-MedLine.d211.s0.e0" e2="DDI-MedLine.d211.s0.e2" ddi="false" flags="True" e1_name="lenalidomide" e2_name="lenalidomide" e1_pos="4" e2_pos="16" path="4@@2@@14@@16@@">lenalidomide@@@@prep_of@@trial@@dep@@evidence@@prep_for@@lenalidomide</pair>  
      <pair id="DDI-MedLine.d211.s0.p2" e1="DDI-MedLine.d211.s0.e0" e2="DDI-MedLine.d211.s0.e3" ddi="false" flags="True" e1_name="lenalidomide" e2_name="CCI-779" e1_pos="4" e2_pos="18" path="4@@2@@19@@18@@">lenalidomide@@@@prep_of@@trial@@dep@@interaction@@nn@@CCI-779</pair>  
      <pair id="DDI-MedLine.d211.s0.p3" e1="DDI-MedLine.d211.s0.e1" e2="DDI-MedLine.d211.s0.e2" ddi="false" flags="True" e1_name="CCI-779" e2_name="lenalidomide" e1_pos="6" e2_pos="16" path="6@@2@@14@@16@@">CCI-779@@@@prep_of@@trial@@dep@@evidence@@prep_for@@lenalidomide</pair>  
      <pair id="DDI-MedLine.d211.s0.p4" e1="DDI-MedLine.d211.s0.e1" e2="DDI-MedLine.d211.s0.e3" ddi="false" flags="True" e1_name="CCI-779" e2_name="CCI-779" e1_pos="6" e2_pos="18" path="6@@2@@19@@18@@">CCI-779@@@@prep_of@@trial@@dep@@interaction@@nn@@CCI-779</pair>  
      <pair id="DDI-MedLine.d211.s0.p5" e1="DDI-MedLine.d211.s0.e2" e2="DDI-MedLine.d211.s0.e3" ddi="false" flags="True" e1_name="lenalidomide" e2_name="CCI-779" e1_pos="16" e2_pos="18" path="16@@14@@2@@19@@18@@">lenalidomide@@@@prep_for@@evidence@@dep@@trial@@dep@@interaction@@nn@@CCI-779</pair> 
   </sentence>  
   <sentence id="DDI-MedLine.d211.s1" text="Multiple myeloma (MM) is an incurable plasma-cell neoplasm for which most treatments involve a therapeutic agent combined with dexamethasone. " new_text="Multiple@@myeloma@@(MM)@@is@@an@@incurable@@plasma-cell@@neoplasm@@for@@which@@most@@treatments@@involve@@a@@therapeutic@@agent@@combined@@with@@dexamethasone@@.@@"> 
      <entity id="DDI-MedLine.d211.s1.e0" charOffset="127-139" type="drug" text="dexamethasone" position="18"/> 
   </sentence>  
   <sentence id="DDI-MedLine.d211.s2" text="The preclinical combination of lenalidomide with the mTOR inhibitor CCI-779 has displayed synergy in vitro and represents a novel combination in MM." new_text="The@@preclinical@@combination@@of@@lenalidomide@@with@@the@@mTOR@@inhibitor@@CCI-779@@has@@displayed@@synergy@@in@@vitro@@and@@represents@@a@@novel@@combination@@in@@MM@@.@@"> 
      <entity id="DDI-MedLine.d211.s2.e0" charOffset="31-42" type="drug" text="lenalidomide" position="4"/>  
      <entity id="DDI-MedLine.d211.s2.e1" charOffset="68-74" type="drug" text="CCI-779" position="9"/>  
      <pair id="DDI-MedLine.d211.s2.p0" e1="DDI-MedLine.d211.s2.e0" e2="DDI-MedLine.d211.s2.e1" ddi="true" type="effect" flags="True" e1_name="lenalidomide" e2_name="CCI-779" e1_pos="4" e2_pos="9" path="4@@9@@">lenalidomide@@@@prep_with@@CCI-779</pair> 
   </sentence> 
</document>
